Curative hepatitis C courses and long-term antivirals.
Sofosbuvir is used to treat certain types of chronic hepatitis C (an ongoing viral infection that damages the liver) in adults. Sofosbuvir is in a class of antiviral medications called nucleotide polymerase inhibitors.
A once-daily tablet that cures most hepatitis C over a 12-week course.
The combination of ledipasvir and sofosbuvir is used alone or in combination with ribavirin (Copegus, Rebetol, Ribasphere, others) to treat certain types of chronic hepatitis C (an ongoing viral infection that damages the liver) in adults and children 3 years of age and older.
A vaccine used to provide immunity against hepatitis A and hepatitis B.
A long-term antiviral for chronic hepatitis B.
Ribavirin capsules are a nucleoside analogue indicated in combination with interferon alfa-2b (pegylated and nonpegylated) for the treatment of Chronic Hepatitis C (CHC) in patients 3 years of age or older with compensated liver disease.
Ribavirin is used with an interferon medication such as peginterferon alfa-2a [Pegasys] or peginterferon alpha-2b [PEG-Intron]) to treat hepatitis C in people who have not been treated with an interferon before.